Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study

MetS and its components have been found to be associated with an increased risk of OA, particularly in individuals with elevated levels of CRP. These findings highlight the significance of managing MetS as a preventive and intervention measure for OA.